Kinesio taping, or 'KT tape' as it's usually known—widely used to ease joint/muscle pain and boost range of movement—may not be all that effective, suggests a pooled data analysis of the existing evidence, published in the online journal BMJ Evidence Based Medicine.
The cotton-based, breathable, adhesive tape, often seen on the bodies of high profile athletes and sportsmen and women, may confer immediate to short term benefits, but the current evidence is "very uncertain," say the researchers.
The lack of strong evidence, plus the potential associated skin irritation, may limit its use in clinical practice, they conclude.
Kinesio (KT) taping, originally created in the 1970s, has been extensively used for easing the discomfort of musculoskeletal disorders and increasing mobility, explain the researchers.
If applied correctly, it is thought to work by lifting the skin, stimulating sensory receptors, and enhancing local blood circulation, but several recent clinical trials have reported inconsistent findings for its use, they add.
In a bid to clarify the current body of evidence, the researchers set out to summarise the findings on the use of KT taping for pain intensity, function/disability, range of movement, muscle strength, quality of life and specific disease symptoms.
They scoured research databases looking for relevant systematic reviews on the use of KT taping as the primary treatment for musculoskeletal disorders, spanning the period since its introduction until October 2025.
Their pooled data analysis included 128 English language systematic reviews, 73 of which were published, and 55 of which were registered but not yet published. These reviews covered 310 individual randomised clinical trials, involving 15,812 participants and 29 musculoskeletal conditions across different therapeutic timeframes.
Most of the reviews looked at conditions affecting the legs and feet (45%) and pain intensity (89%).
Synthesis of the systematic review findings indicated that KT taping may reduce pain intensity in the immediate and short term and improve function/disability in the immediate term, but the evidence is highly uncertain.
This includes its use in a range of common conditions, such as after knee surgery, for chronic knee or back pain, knee osteoarthritis, tennis elbow (lateral elbow tendinopathy), and plantar fasciitis.
And inconclusive evidence suggests that KT taping may have trivial or negligible effects on pain intensity in the medium term, function/disability in the short and medium term, and on muscle strength, range of movement, and disease-specific musculoskeletal symptoms.
KT taping may only be marginally (i.e., minimal clinically important differences) better than placebo/sham taping, although the certainty of this evidence is low, and its effects may vary across different groups of patients or conditions, note the researchers.
Just 19 of the trials reported on side effects, the most common of which were skin irritation
(40%) and itching (30%). Although these generally cleared up without further treatment, the skin irritation and itching "remain concerns," say the researchers.
There wasn't enough evidence to confirm whether or not KT taping improves quality of life in people with musculoskeletal disorders.
The methodology of most (57; 78%) of the systematic reviews was flawed and varied considerably in design. And there was a considerable degree of overlap among them, making it difficult to offer firm recommendations on its use, highlight the researchers.
They conclude: "Current evidence is very uncertain regarding the clinical effects of KT [taping] on [musculoskeletal disorders]. Considerable heterogeneity, unclear clinical relevance, and potential [side effects] may limit its application in clinical practice."
